Cover Story

The incidence of hepatocellular carcinoma (HCC) is increasing. This is proposed to be, in part, the result of the high prevalence of metabolic diseases. Dysregulated metabolism is an important contributor to the pathogenesis of cancer. Experimental models suggest that impeding glucose production promotes HCC, while enhancing glucose production has the opposite effect. The role of liver glycine N-methyltransferase (GNMT) in the relationship between glucose control and HCC is of particular interest. In humans with HCC, liver GNMT can be greatly decreased. Moreover, GNMT-null mice develop HCC by eight months of age suggesting a causal role for impaired GNMT action in tumorigenesis.

Hughey et al. studied the relationship of GNMT action and glucose production to HCC formation. The results show that the lack of GNMT reduces glucose production from glycogen and gluconeogenic sources. Reduced glucose production is coupled to impaired NAD+ synthesis and salvage. Results show a decline in NAD+ availability may diminish glucose production directly and/or by redirecting flux of glucose precursors to pathways that regulate liver redox state and tumorigenesis.

Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.



Anastasia Kralli, Yoshitake Cho
The Scripps Research Institute, La Jolla, CA, USA
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at www.sciencedirect.com/journal/molecular-metabolism
Conferences & Events
May 29 −
June 1
2019
Diabetes Kongress 2019
Berlin, Germany
June
3 − 4
2019
CPH BAT 2019
Copenhagen, Denmark
June
7 − 11
2019
ADA Scientific Sessions
San Francisco, California
June 30 −
July 1
2019
ATLAS Symposium 2019
Middelfart, Denmark
August
25 − 30
2019
Epigenomics, Nuclear Receptors and Disease
Spetses Island, Greece
September
9 − 12
2019
Ageing and Regeneration
Innsbruck, Austria
September
23 − 25
2019
7th Helmholtz Diabetes Conference
Munich, Germany
Media Coverage
Supported by